Trials / Sponsors / Cylene Pharmaceuticals
Cylene Pharmaceuticals
Industry · 6 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | Study of CX-4945 in Patients With Relapsed or Refractory Multiple Myeloma Multiple Myeloma | Phase 1 | 2010-09-01 |
| Unknown | Dose-escalation Study of Oral CX-4945 Advanced Solid Tumors, Breast Cancer, Inflammatory Breast Cancer | Phase 1 | 2009-02-01 |
| Completed | Quarfloxin in Patients With Low to Intermediate Grade Neuroendocrine Carcinoma Neuroendocrine Tumors, Carcinoid Tumor | Phase 2 | 2008-10-01 |
| Terminated | Dose-escalation Study of Quarfloxin in Patients With Advanced Solid Tumors or Lymphomas Advanced Solid Tumors, Lymphoma | Phase 1 | 2007-07-01 |
| Withdrawn | Study Evaluating Effects of CX-3543 in Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemi B-Cell Chronic Lymphocytic Leukemia | Phase 2 | 2007-06-01 |
| Completed | Dose-escalation Study of CX-3543 in Patients With Advanced Solid Tumors or Lymphomas Advanced Solid Tumors, Lymphoma | Phase 1 | 2005-07-01 |